Rituximab-induced pulmonary disease

Rheumatol Int. 2012 Sep;32(9):2955-6. doi: 10.1007/s00296-011-2110-9. Epub 2011 Sep 3.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Amoxicillin-Potassium Clavulanate Combination / therapeutic use
  • Antibodies, Monoclonal, Murine-Derived / adverse effects*
  • Antibodies, Monoclonal, Murine-Derived / therapeutic use
  • Antirheumatic Agents / adverse effects*
  • Antirheumatic Agents / therapeutic use
  • Arthritis / drug therapy
  • Clarithromycin / therapeutic use
  • Drug Therapy, Combination
  • Humans
  • Hydrocortisone / therapeutic use
  • Lung Diseases, Interstitial / chemically induced*
  • Lung Diseases, Interstitial / diagnosis*
  • Lung Diseases, Interstitial / drug therapy
  • Male
  • Middle Aged
  • Prednisolone / therapeutic use
  • Rituximab
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal, Murine-Derived
  • Antirheumatic Agents
  • Rituximab
  • Amoxicillin-Potassium Clavulanate Combination
  • Prednisolone
  • Clarithromycin
  • Hydrocortisone